| Literature DB >> 25883658 |
Suleyman Koz1, Idris Sahin2, Zafer Terzi3, Sema Tulay Koz4.
Abstract
End-stage kidney disease and advanced cirrhosis are sometimes seen concomitantly. There is no consensus on dialysis modality in terms of determining the optimal way of treating these patients. It has been suggested that peritoneal dialysis is a better choice for these patients, but efficacy of hemodialysis in stable cirrhotic patients has not been evaluated sufficiently. We report a case with advanced cirrhosis and end-stage kidney disease who was faced with hepatic encephalopathy episodes up on starting renal replacement therapy. The case is also interesting in that it reveals effects of hemodialysis and peritoneal dialysis on hepatic encephalopathy episodes and quality of life of the patient.Entities:
Year: 2015 PMID: 25883658 PMCID: PMC4389984 DOI: 10.1155/2015/375456
Source DB: PubMed Journal: Case Rep Med
Figure 1Mean Na, K, and albumin levels of the patient during PreD, PD and HD periods. The numbers on the graph lines represent the means. *Na: Na level of PD is significantly lower than that of PreD, P = 0.004. Differences between other groups are not significant. **K: K level of PD is significantly lower than that of PreD P = 0.006, and K level of HD is significantly lower than that of PreD P = 0.01. The difference between mean K level of PD and HD periods is not significant. ***Albumin: differences between groups are not statistically significant. n: number of laboratory values in the relevant period, PreD: predialysis period, PD: peritoneal dialysis period, and HD: hemodialysis period. Comparisons between groups were done by using Wilcoxon Signed Rank Test (Statistical Package designed for the Social Sciences (SPSS) software, version 17.0 (SPSS Inc., Chicago, IL, USA)), and P < 0.05 was considered as statistically significant.